Terminated OBSERVATIONAL NCT01090791

FLOTRAC/VIGILEO in Acute Circulatory Failure (FLOVAC)

Assessment of the FLOTRAC/VIGILEO Third Generation Software to Predict Fluid Responsiveness in Critically Ill Patient With Acute Circulatory Failure

Sponsor: Hôpital Européen Marseille

Conditions Acute Circulatory Failure Critically Ill Fluid Loading

Interventions Flotrac/Vigileo third generation software Transthoracic echocardiography

Updated 6 times since 2017 Last updated: Sep 7, 2016 Started: May 31, 2011 Primary completion: Sep 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Major change in protocol anticipated

Other terminated trials from Hôpital Européen Marseille

See all terminations from Hôpital Européen Marseille

This observational or N/A phase trial investigates Acute Circulatory Failure and Critically Ill and is currently terminated or withdrawn. Hôpital Européen Marseille leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated
Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Terminated NA

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hôpital Européen Marseille

Data source: Hôpital Européen Marseille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marseille, France